EB-2 (NIW) for Israeli Nationals

USCIS I-140 petition data for Israel nationals (FY2025 Q4 (Jul-Sep 2025)).

29 I-140 petitions 7 approved #35 by volume
Subcategory:

USCIS I-140 Data

Israel I-140 Petition Statistics

USCIS EB-2 (NIW) petition data for Israel nationals. FY2025 Q4 (Jul-Sep 2025).

I-140 Receipts

29

0.1% of all

I-140 Approvals

7

of 5,929 total

Volume Rank

#35

by I-140 receipts

Source: USCIS I-140 Performance Data, FY2025 Q4 (Jul-Sep 2025). Receipts and approvals for the reporting quarter.

Priority Date Tracker

Final Action Date

Oct 2024

ROW Final Action

Oct 2024

Source: DOS Visa Bulletin (2026-03)

Wait Time Estimator

Estimate Your Green Card Timeline

Enter your priority date and country to get a personalized estimate based on average DOS Final Action Date advancement over the last 12 months.

EB-2 (incl. NIW)

Sources: I-140/I-485 ranges from USCIS Processing Times, backlog advancement averaged over last 12 DOS Visa Bulletins. Estimates only.

Find Israeli EB-2 (NIW) Cases

Browse real petition decisions and case studies from Israel, or join the waitlist to get notified when personalized case matching launches.

Country Comparison

USCIS I-140 data, FY2025 Q4 (Jul-Sep 2025)

CountryReceiptsApprovals
Grand Total 13,9832,968
China 2,330715
India 1,685426
Israel (current)297
Case Data Insights

We analyzed 7 publicly available EB-2 (NIW) petition decisions involving Israel nationals. Of these, 71% were approved or sustained, 2 denied. These cases span 5 industries and 6 job titles. Explore the charts below to see how decision outcomes have trended over time and which industries and roles have the highest success rates.

Decision Trends

0122022-042022-082022-122023-042023-082023-122024-042024-082024-122025-04
Approved
Remanded
Denied

Top Industries

Healthcare 2
Research and Development 2
Education 1
Materials Science 1
Software 1

Top Job Titles

Doctor 2
Chief Executive Officer (CEO) 1
Entrepreneur 1
Physicist 1
Research Scientist 1
Researcher 1

Policy Updates

General View all
Mar 2026 info Visa Bulletin

Visa Bulletin Update: EB-2 (2026-03)

The Department of State updated EB-2 Final Action Dates in the 2026-03 Visa Bulletin: - India: moved from 2013-07-15 to 2013-09-15 - Philippines: moved from 2024-04-01 to 2024-10-15 - Mexico: moved from 2024-04-01 to 2024-10-15 - Rest of World: moved from 2024-04-01 to 2024-10-15 This may allow additional applicants to proceed with their petitions.

advancementeb-2final-action-datepriority-date
Feb 2026 info Executive Order
Protecting the National Security and Welfare of the United States and its Citizens from Criminal Actors and Other Public Safety Threats

The policy directs DHS to maximize its use of criminal history record information (CHRI) for screening and vetting missions. This includes reciprocal data sharing with foreign governments, which will likely be utilized during the adjudication of EB-2 visas and National Interest Waivers.

vettingbackground checkssecurity screeningNIW
Jan 2026 warning USCIS Alert
USCIS to Increase Premium Processing Fees

The fee for Form I-907 is being adjusted upwards, impacting EB-2 petitioners who utilize expedited processing. This change is part of a broader USCIS effort to adjust fees for inflation and maintain service levels.

premium processinguscis feesNIWform i-907
Jan 2026 warning USCIS Memo
DHS Launches Landmark USCIS Fraud Investigation in Minnesota

The investigation focuses on identifying fraudulent activities within USCIS filings in the Minnesota region. EB-2 applicants may experience heightened vetting procedures, including more frequent Requests for Evidence (RFEs) and audits of employer credentials. This initiative is part of a broader DHS effort to ensure the integrity of employment-based immigration programs.

fraud investigationcomplianceUSCISDHS
Jan 2026 info Visa Bulletin

Visa Bulletin Update: EB-2 (2026-01)

The Department of State updated EB-2 Final Action Dates in the 2026-01 Visa Bulletin: - India: moved from 2013-05-15 to 2013-07-15 - China: moved from 2021-06-01 to 2021-09-01 - Philippines: moved from 2024-02-01 to 2024-04-01 - Mexico: moved from 2024-02-01 to 2024-04-01 - Rest of World: moved from 2024-02-01 to 2024-04-01 This may allow additional applicants to proceed with their petitions.

advancementeb-2final-action-datepriority-date

Frequently Asked Questions

At a Glance

USCIS Official Data

I-140 Receipts 29
I-140 Rank #35 of 191

Scraped Case Data

Decisions 7
Success Rate 71%
Country Share 0.2%
Approved / Sustained 5
Denied / Dismissed 2
Top Industry Healthcare
Top Job Title Doctor

Recent Decisions

View all

Doctor

Healthcare · Israel

WeGreened approved
13 days 2025-05-28
The petitioner proposes to utilize advanced genome sequencing, immunoprofiling, and real-world patient data to uncover genetic and immune mechanisms underlying pediatric diseases. The work focuses on developing early diagnostic tools and targeted, individualized therapies for pediatric autoimmune and neurodevelopmental disorders.
View Case

Physicist

Research and Development · Israel

WeGreened approved
Texas 343 days 2025-04-11
The petitioner proposes to develop cutting-edge X-ray beam radiotherapy systems that precisely target tumors while minimizing radiation exposure to healthy tissue. This work involves leveraging advanced optical methods and quantum-enhanced X-ray detection to improve the safety and effectiveness of radiation treatments. The research aims to advance high-precision X-ray delivery and real-time imaging technologies for oncology applications.
View Case

Research Scientist

Research and Development · Israel

WeGreened approved
Massachusetts 60 days 2025-02-05
The petitioner proposes to develop advanced mathematical algorithms and databases designed to identify connections between mathematical structures, state conjectures, and generate counterexamples. This work aims to provide essential tools for big data analysis, cryptographic systems, and computational modeling to enhance scientific discovery.
View Case

Doctor

Healthcare · Israel

WeGreened approved
Ohio 56 days 2024-12-17
The petitioner proposes to advance the understanding of complex genetic disorders through the development of innovative genetic engineering models and tailored drug design methodologies. This work specifically focuses on investigating somatic mutations in the brains of individuals with Alzheimer’s disease to identify new pathways for diagnosis and therapeutic intervention. The endeavor aims to support the medical community in treating neurodegenerative processes and syndromic autism.
View Case

Chief Executive Officer (CEO)

Software · Israel

USCIS rfe dismissed
Israel 2024-10-15
The petitioner proposes to expand his company, which provides artificial intelligence (AI) enabled customer experience software, by implementing it in medium to large organizations in the U.S. and globally. He intends to partner with certified distributors and consultants to deliver innovative AI capabilities, boost customer engagement, and provide exceptional return on investment, while also relocating his company from Israel to the U.S. and developing an innovation center in Ohio.